User:Mpennipep

Michael W. Pennington, PhD President and COO of Bachem Bioscience, Inc. Dr. Pennington possesses over 25 years experience in the chemistry, pharmacology, manufacturing, and sale of pharmaceutical peptides and small molecules. He is also an Adjunct Faculty Member in Chemistry at Villanova University and has authored over 90 publications in peer-reviewed journals. He has been the co-editor to highly successful Method in Molecular Biology volumes dedicated the peptide synthesis and analytical methods. Prior to joining Bachem Bioscience Inc. (http://www.bachem.com), Dr. Pennington worked at Schering-Plough Laboratories in the biotechnology group dedicated to manufacturing Interferon and G-CSF. Dr. Pennington is a co-inventor of ShK-186 and an Airmid co-founder. He received his Ph.D. from the University of Florida in Biochemistry and Molecular Biology with Dr. Ben M. Dunn as his mentor and his Bachelors of Science in Chemistry from University of North Carolina, Chapel Hill in the laboratory of Dr. Richard Hiskey.

Dr. Pennington is now involved in consulting activities with the Toxinomics Foundation in Geneva, Switzerland (www.toxinomics.org) and his own private peptide consulting opportunities,http://www.pennipeptide.com.